In a study involving Ugandan children, McDonald et al., reported that lower BDNF levels were associated with poor prognosis in patients with CM, whereas higher levels of BDNF resulted in faster recovery from coma35. This evidence concerns the gene BDNF and cutaneous mastocytosis.